These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

220 related items for PubMed ID: 17630612

  • 1. The role of recombinant insulin-like growth factor I in the treatment of the short child.
    Rosenbloom AL.
    Curr Opin Pediatr; 2007 Aug; 19(4):458-64. PubMed ID: 17630612
    [Abstract] [Full Text] [Related]

  • 2. Recombinant human insulin-like growth factor-I therapy for children with growth disorders.
    Richmond EJ, Rogol AD.
    Adv Ther; 2008 Dec; 25(12):1276-87. PubMed ID: 19066756
    [Abstract] [Full Text] [Related]

  • 3. Insulin-like growth factor-I (rhIGF-I) therapy of short stature.
    Rosenbloom AL.
    J Pediatr Endocrinol Metab; 2008 Apr; 21(4):301-15. PubMed ID: 18556960
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Mecasermin: new drug. Insufficient improvement in statural growth.
    Prescrire Int; 2009 Jun; 18(101):111-3. PubMed ID: 19637420
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Abnormal growth in noonan syndrome: genetic and endocrine features and optimal treatment.
    Padidela R, Camacho-Hübner C, Attie KM, Savage MO.
    Horm Res; 2008 Jun; 70(3):129-36. PubMed ID: 18663312
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Treatment perspectives in idiopathic short stature with a focus on IGF-I deficiency.
    Rosenthal S, Cohen P, Clayton P, Backeljauw P, Bang P, Ten S.
    Pediatr Endocrinol Rev; 2007 May; 4 Suppl 2():252-71. PubMed ID: 17581497
    [No Abstract] [Full Text] [Related]

  • 12. Insulin-like growth factor-I treatment of growth disorders, diabetes mellitus and insulin resistance.
    Ranke MB.
    Trends Endocrinol Metab; 2005 May; 16(4):190-7. PubMed ID: 15860416
    [Abstract] [Full Text] [Related]

  • 13. Growth hormone therapy for short children born small for gestational age.
    Chatelain P, Carrascosa A, Bona G, Ferrandez-Longas A, Sippell W.
    Horm Res; 2007 May; 68(6):300-9. PubMed ID: 17823537
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Statement 5: the first line of treatment for children with idiopathic short stature (ISS) and low serum insulin-like growth factor-I (IGF-I) should be IGF-I.
    Backeljauw P.
    Pediatr Endocrinol Rev; 2008 Apr; 5 Suppl 3():853-6. PubMed ID: 18438329
    [No Abstract] [Full Text] [Related]

  • 16. Principles of growth hormone and insulin-like growth factor-I treatment in children with idiopathic short stature.
    Bang P.
    Horm Res Paediatr; 2011 Apr; 76 Suppl 3():24-6. PubMed ID: 21912155
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Growth hormone deficiency in children: an approach to a child with short stature.
    Chowdhury S, Chatterjee P.
    J Indian Med Assoc; 2004 Aug; 102(8):446, 449-52. PubMed ID: 15719807
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Insulin-like growth factor I and growth responses during the first year of growth hormone treatment in KIGS patients with idiopathic growth hormone deficiency, acquired growth hormone deficiency, turner syndrome and born small for gestational age.
    Cutfield WS, Lundgren F.
    Horm Res; 2009 Jan; 71 Suppl 1():39-45. PubMed ID: 19153504
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.